Modular theranostic prodrug based on a FRET-activated self-immolative linker

Orit Redy, Doron Shabat

Research output: Contribution to journalArticlepeer-review


New chemotherapeutic prodrugs that can report on the localization and activation of the drug upon internalization into select cells are being widely investigated for cancer treatment. Here, we introduce a new molecular design for a theranostic prodrug based on a self-immolative linker attached to a pair of FRET dyes that produces a fluorescent signal upon disassembly. The prodrug evaluated here was designed to release the chemotherapeutic drug camptothecin upon activation by the model enzyme penicillin-G-amidase. Similar patterns of the disassembly of the prodrug were observed in HPLC and fluorescence assays. The obtained results demonstrate that upon specific activation of the prodrug, the increase of the emitted fluorescent signal is linearly correlated with the observed drug release. Such a design could potentially be used to monitor prodrug activation in real-time and provide information regarding the location and the amount of active drug molecules.

Original languageEnglish
Pages (from-to)276-282
Number of pages7
JournalJournal of Controlled Release
Issue number3
StatePublished - 28 Dec 2012


  • Prodrug
  • Self-immolative linker
  • Theranostics

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science


Dive into the research topics of 'Modular theranostic prodrug based on a FRET-activated self-immolative linker'. Together they form a unique fingerprint.

Cite this